30Dec 2017

CLINICAL AND LABORATORY EVALUATION OF ADRENOMEDULLIN AS A BIOMARKER IN MODERATE CHRONIC PERIODONTITIS.

  • B.D.S. Faculty of Dentistry Sirte University, Libya.
  • Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University.
  • Professor of Clinical Pathology, Faculty of Medicine, Mansoura University.
  • Ass. Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: The aim of this study was to determine the effect of non surgical periodontal treatment on GCF level of adrenomedullin and interleukin 1 βeta in patients with moderate chronic periodontitis. Subjects and Methods: A total of thirty subjects was included in this study; 15 subjects with moderate chronic periodontitis (group I) and 15 systemically healthy subjects with clinically healthy gingiva as a control group (group II). Periodontal parameters, including Plaque index (PI), Gingival index (GI), bleeding on probing (BOP), Periodontal probing depth (PPD) and Clinical attachment level (CAL), were recorded in all the sites from both groups. The first GCF samples were collected from both groups (study and control) at the start of study. Nonsurgical periodontal therapy was done to group I. The same periodontal parameters were recorded again and the second GCF samples were collected again after 4 weeks after phase I therapy from group I. Levels of IL-1β and adrenomedullin in GCF were quantified using ELISA. Results: At baseline the level of IL-1β and ADM in gingival crevicular fluid was significantly higher in chronic periodontitis patients than in healthy subjects. The results of the present study, showed a significant reduction in all clinical parameters (GI, PI, PPD, BOP and CAL) after phase I periodontal therapy in chronic periodontitis group. Level of IL-1β and ADM in gingival crevicular fluid were significantly decreased after a phase I periodontal therapy in moderate chronic periodontitis group when compared to their levels at baseline. Conclusions: Scaling and root planing (SRP) is the mainstay of treatment of periodontal diseases as SRP was effective in improving clinical parameters in patients with chronic periodontitis. ADM could be used as a potential diagnostic marker for periodontal disease in gingival crevicular fluid.

  1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. Journal of Periodontology. 1992;63(4s):322-31.
  2. Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, et al. In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. Journal of Antimicrobial Chemotherapy. 2006;58(1):198-201.
  3. Yaghobee S, Khorsand A, Paknejad M. Comparison of interleukin-1β levels in gingival crevicular fluid and peri-implant crevicular fluid and its relationship with clinical indexes. Journal of Dentistry of Tehran University of Medical Sciences. 2013;10(1):1-9.
  4. Faizuddin M, Bharathi S, Rohini N. Estimation of interleukin‐1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. Journal of periodontal research. 2003;38(2):111-4.
  5. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respiratory research. 2000;1(3):141-50.
  6. Lundy FT, O?Hare MM, McKibben BM, Fulton CR, Briggs JE, Linden GJ. Radioimmunoassay quantification of adrenomedullin in human gingival crevicular fluid. Archives of oral biology. 2006;51(4):334-8.
  7. Allaker RP, Grosvenor PW, McAnerney DC, Sheehan BE, Srikanta BH, Pell K, et al. Mechanisms of adrenomedullin antimicrobial action. Peptides. 2006;27(4):661-6.
  8. Santos VR, Ribeiro FV, Lima JA, Napimoga MH, Bastos MF, Duarte PM. Cytokine levels in sites of chronic periodontitis of poorly controlled and well‐controlled type 2 diabetic subjects. Journal of clinical periodontology. 2010;37(12):1049-58.
  9. Teng Y-T. Protective and destructive immunity in the periodontium: part 1?innate and humoral immunity and the periodontium. Journal of dental research. 2006;85(3):198-208.
  10. Suchetha A, Garg A, Lakshmi P, Bhat D, Sapna N, Apoorva S. -Adrenomedullin, periodontitis, diabetes-unraveling the equivocal relationship: A clinicobiochemical cross sectional study Contemporary clinical dentistry. 2013;4(4):454-9.
  11. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Current issues in molecular biology. 2005;7(2):119-33.
  12. Gupta G. Gingival crevicular fluid as a periodontal diagnostic indicator-II: inflammatory mediators, host-response modifiers and chair side diagnostic aids. Journal of medicine and life. 2013;6(1):7-13.
  13. Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontology 2000. 2016;70(1):53-64.
  14. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Critical Reviews in Oral Biology & Medicine. 1998;9(3):248-66.
  15. Gorr SU. Antimicrobial peptides of the oral cavity. Periodontology 2000. 2009;51(1):152-80.
  16. Lamster IB, Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Annals of the New York Academy of Sciences. 2007;1098(1):216-29.
  17. Griffiths G, Wilton J, Curtis M. Contamination of human gingival crevicular fluid by plaque and saliva. Archives of oral biology. 1992;37(7):559-64.
  18. Ghodpage PS, Kolte RA, Kolte AP, Gupta M. Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1. The Saudi dental journal. 2014;26(4):171-5.
  19. Lamster I, Ahlo J. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann N Y Acad Sci. 2007;1098:216-29.
  20. AbdulAziz S, Madhav G, Tabita B, Adinath N, Milsee M, Mohammed N. Effect of Nonsurgical Periodontal Therapy on Some Oxidative Stress Markers in Patients with Chronic Periodontitis: A Biochemical Study. World Journal of Dentistry. 2013;4:17-23.
  21. Carvalho L, D'avila G, Leao A, Haffajee A, Socransky S, Feres M. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. Journal of clinical periodontology. 2004;31(12):1070-6.
  22. Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin‐1β, prostaglandin E2 and periodontal status in a community population. Journal of clinical periodontology. 2007;34(4):285-93.
  23. Rosalem W, Rescala B, Teles RP, Fischer R, Gustafsson A, Figueredo C. Effect of non-surgical treatment on chronic and aggressive periodontitis: clinical, immunologic, and microbiologic findings. Journal of periodontology. 2011;82(7):979-89.
  24. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL‐1β profiles in periodontal disease. Journal of clinical periodontology. 2002;29(1):48-53.
  25. Yousefimanesh H, Robati M, Jahangirnezhad M, Ghafourian M, Jamili R, Jafari P. Evaluation of non surgical treatment effect on salivary interleukin-1 beta (IL 1β) in patientswith periodontitis. E-Journal of Dentistry. 2014;4(4):656-62.
  26. T?rkoğlu O, Emingil G, K?t?k??ler N, Atilla G. Evaluation of gingival crevicular fluid adrenomedullin and human neutrophil peptide 1?3 levels of patients with different periodontal diseases. Journal of periodontology. 2010;81(2):284-91.
  27. Kapas S, Pahal K, Cruchley A, Hagi-Pavli E, Hinson J. Expression of adrenomedullin and its receptors in human salivary tissue. Journal of dental research. 2004;83(4):333-7.
  28. Elsasser TH, Kahl S. Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microscopy research and technique. 2002;57(2):120-9.
  29. Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, Sum CF. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care. 2007;30(6):1513-9.
  30. Ruzicska E, Toth M, Tulassay Z, Somogyi A. Adrenomedullin and diabetes mellitus. Diabetes/metabolism research and reviews. 2001;17(5):321-9.
  31. Kapas S, Bansal A, Bhargava V, Maher R, Malli D, Hagi-Pavli E, et al. Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides. 2001;22(9):1485-9.
  32. Lamster IB, Oshrain RL, Gordon JM. Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. Journal of Clinical Periodontology. 1986;13(8):799-804.
  33. Hosokawa I, Hosokawa Y, Ozaki K, Nakae H, Matsuo T. Adrenomedullin suppresses tumour necrosis factor alpha‐induced CXC chemokine ligand 10 production by human gingival fibroblasts. Clinical & Experimental Immunology. 2008;152(3):568-75.
  34. Isumi Y, Minamino N, Katafuchi T, Yoshioka M, Tsuji T, Kangawa K, et al. Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells. Endocrinology. 1998;139(5):2552-63.
  35. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Interleukin-1, Tumor Necrosis Factor and Lipopolysaccharide Additively Stimulate Production of Adrenomedullin in Vascular Smooth Muscle Cells. Biochemical and Biophysical Research Communications. 1995;207(1):25-32.

[Shahawi M. Salim, Jilan M. Youssef , Shereen Salah and Mohamed M. Anees . (2017); CLINICAL AND LABORATORY EVALUATION OF ADRENOMEDULLIN AS A BIOMARKER IN MODERATE CHRONIC PERIODONTITIS. Int. J. of Adv. Res. 5 (Dec). 1622-1628] (ISSN 2320-5407). www.journalijar.com

shahawi mahammed salim

DOI:

Article DOI: 10.21474/IJAR01/6126      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6126

Download Full Paper

Download PDF No. of Downloads: 13 | No. of Views: 99